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Abstract 
Purpose: To assess the memory-enhancing effect of Cistanche deserticola Ma (Orobanchaceae) 
extract (CDME) on normal aged mice.  
Methods: An open-field test was used to study the effects of various doses of CDME on mouse 
locomotive activity. The mice were sacrificed following the locomotor test and the brain dissected to 
investigate the effects of CDME on catalase (CAT) and acetyl cholinesterase (AChE) activities in mouse 
brain tissue. 
Results: Compared with the control aged group, CDME (400 mg/kg) significantly reduced the total 
distance traveled (3312.5 ± 119.3 cm, p < 0.05), increased brain CAT activity (107.6 ± 11.8U/mg pro, p 
< 0.05), and inhibited brain AChE activity (0.89 ± 0.13 U/mg pro, p < 0.05) in CDME-exposed mice.  
Conclusion: The results show that CDME improves memory function in mice, probably by increasing 
the activity of CAT and decreasing AChE activity. 
 
Keywords: Cistanche deserticola Ma, Memory function, Catalase, Acetyl cholinesterase, Open-field 
test 
 
Tropical Journal  of Pharmaceutical Research is indexed by Science Citation Index (SciSearch), Scopus, 
International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African 
Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals 




Age-related learning and memory disorders have 
become more prevalent as human life 
expectancy has increased and constitute a major 
global healthcare issue. To combat these issues, 
it is vital to develop effective prophylactic and 
therapeutic agents for enhancing and 
maintaining memory functions before the onset 
of memory impairment in the aging population [1-
3]. Traditional Chinese medicine has been used 
for improving memory and treating cognitive 
deficits for thousands of years. Cistanche 
deserticola Ma (Orobanchaceae) is a well-known 
medicinal shrub-like herb that has been 
commonly used as memory enhancer in China. 
Cistanche deserticola Ma (Orobanchaceae) 
extract (CDME) is also included in some 
traditional prescriptions for treating central 
nervous system disturbances [4-6]. This study 
was designed to investigate the effects of CDME 
on learning and memory impairment in normal 
aged mice. Learning and memory parameters 
were evaluated using an open-field test, and 
brain tissue catalase (CAT) and acetyl 
cholinesterase (AChE) activities were analyzed 





Plant material and extraction  
 
Cistanche deserticola Ma (Orobanchaceae) 
whole plant was collected in Kashi City, Xinjiang 
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Province, China, in October 2015. Taxonomic 
identification of the plant was made by Professor 
Heping Hu of Chongqing Medical University 
(Chongqing, China). A voucher specimen of 
Cistanche deserticola Ma (no. RRL 20151004) 
was deposited in the herbarium of the College of 
Pharmacy, Chongqing Medical University for 
future reference. 
 
The Cistanche deserticola Ma plant material was 
dried in an oven at 100 °C for 12 h. The plant 
extract (CDME) was obtained by steeping the 
dried Cistanche deserticola Ma in 60 °C water for 
1 h. This extraction process was repeated three 
times. The last extract was freeze-dried to obtain 
a powder. One gram of powder was obtained 
from about 2.0g of dried sample, giving a yield of 
approximately 50.0 %. 
 
Animals and study design 
 
Female C57BL/6J mice (60 mice aged 15 
months and 12 mice aged 3 months) were 
purchased from the Experimental Animal Center 
of Chongqing (certificate no. SYXK 2005-0004). 
The mice were housed in groups of five animals 
per cage and kept under conditions of constant 
temperature (23 ± 2 °C) and humidity (50 ± 10 
%) and a 12 h:12 h light-dark cycle. The animals 
had free access to standard chow diet and 
sterilized drinking water in the SPF Animal 
House. The 3-month-old mice were used as the 
3-month-old normal control group. The 15-
month-old mice were randomly assigned to six 
groups of 10 each, including the 15-month-old 
normal control group, the aged control group, the 
positive control galantamine (3 mg/kg) group, 
and the CDME (100, 200, and 400 mg/kg) 
groups. The mouse experiments were approved 
by the Animal Care and Use Committee of The 
Second Affiliated Hospital of Chongqing Medical 
University (approval ref. no. 20111006) and were 
carried out in compliance with Directive 
2010/63/EU on the handling of animals used for 
scientific purposes [7]. 
 
Drug administration and behavioral assays were 
carried out using double-blind methodology. After 
2 days of feeding, the 15-month-old mice 
received water alone orally (normal control group 
and the aged control group), galantamine at 3 
mg/kg (positive control drug galantamine group), 
or CDME at 100, 200, and 400 mg/kg (L-CDME, 
M-CDME, and H-CDME groups, respectively) for 
a period of 4 weeks. 
 
Locomotive activity of mice was evaluated using 
an open-field test on the first day of behavioral 
testing. Then, the mice were -sacrificed by 
dislocation of cervical vertebrae, and the brain 
tissues were used for assessment of the CAT 




The effect of CDME on mice locomotor activity 
was evaluated automatically using an open-field 
computer-aided controlling system [8,9]. The 
apparatus consisted of four metal tanks (30 cm in 
diameter and 40 cm in height) with a video 
camera fixed at the top. The apparatus was 
illuminated by a light source (120 Lux) on the 
ceiling.  
 
Experiments were performed in a quiet room, 
and four mice were tested simultaneously. Thirty 
minutes after drug administration, the mice were 
placed at the center of the metal tank and 
allowed to explore freely for 5 min. The distance 
traveled by each mouse was measured to 
evaluate the locomotive activity of the mouse. 
 
Preparation of brain tissue samples and 
biochemical evaluation 
 
After behavioral measurements, all the mice 
were sacrificed by dislocation of cervical 
vertebrae. The brain tissues were quickly 
removed, washed with cold saline solution 
followed by 50 mM Tris-HCl buffer (pH 7.4), and 
weighed. Then, the tissues were placed in a 
glass bottle, labeled, and stored in a deep 
freezer (-25 °C) for a maximum of 10 h. The 
tissues were cut into small pieces and then 
homogenized in four volumes of ice-cold Tris-HCl 
buffer (50 mM, pH 7.4) using a glass Teflon 
homogenizer (Elektrocrafts, Mumbai, India) for 2 
min at 5000 rpm.  
 
The homogenate was then centrifuged (Remi, 
India) at 1000 rpm for 10 min to remove the 
debris. The upper supernatant fluid was 
extracted with an equal volume of ethanol and 
centrifuged at 17000 rpm for 30 min. The clear 
upper ethanol layer was removed and used for 
biochemical assay. All the preparations were 
performed at 4 °C. The CAT and AChE contents 
were estimated using commercial kits according 
to the manufacturer’s protocols. 
 
Determination of CAT activity in mouse brain 
tissue  
 
CAT activity was assessed by measuring 
hydrogen peroxide at 405 nm [10,11]. One unit 
(U) of CAT corresponds to the amount of the 
enzyme that hydrolyzes a specified amount (in 
mmol) of hydrogen peroxide per minute at 25 °C. 
Catalase activity was expressed as n moles of 
H2O2 metabolized/mg protein/h. 
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Determination of AChE activity in mouse 
brain tissue  
 
AChE activity was determined as described by 
Ellman et al [12] with some modifications. In 
brief, diluted homogenate (30 µL) was added to 2 
mL of the reaction mixture, which contained 100 
mM phosphate buffer (pH 8.0) and 1.0 mM 5,5-
dithiobis-2-nitrobenzoic acid (DTNB), and 
incubated at 37 °C for 6 min. 
 
Hydrolysis was monitored by determining the 
formation of the thiolate dianion of DTNB at 412 
nm for 3 min in a spectrophotometer. AChE 
activity was calculated from the quotient between 
lymphocyte AChE activity and protein content.  
 
One unit (U) of enzyme activity was defined as 1 
µmol of AChE hydrolyzed/hour/milligram of brain 
homogenate or 1 µmol of AChE 




All data were processed using Statistical 
Package SPSS 16.0 (SPSS Inc, Chicago, IL, 
USA), expressed as mean ± standard error of 
mean (SEM), and analyzed by one-way analysis 
of variance (ANOVA) followed by Dunnett’s t-





Effect of CDME on mouse locomotive activity 
in the open field test 
 
Medium and high doses of CDME (200 and 400 
mg/kg) significantly decreased locomotive 
activities of mice in the open-field test (p < 0.05; 
Table 1). Furthermore, galantamine (3 mg/kg) 
significantly reduced the total distance traveled 
compared with the aged control group (p < 0.05; 
Table 1). 
 
Table 1: Effect of CDME on mouse locomotive activity 
 
Group CDME (mg/kg) Total distance (cm) 
Controla 0 3429±127 
Agedb 0 3842±115 
Galc 3 3228±119* 
L-CDMEd 100 3689±122 
M-CDMEe 200 3515±112* 
H-CDMEf 400 3295±116* 
a15-month-old control; baged control; cgalantamine; 
dlow dose of CDME; emiddle dose of CDME; fhigh 
dose of CDME; *significantly different (p < 0.05) versus 
aged control group (n = 10) 
 
Effect of CDME on CAT activity in mouse 
brain tissue  
 
The CAT activity in brain tissue in aged control 
mice was significantly lower than that in 15-
month-old normal control mice (p < 0.05; Table 
2). However, mice treated with medium and high 
doses of CDME (200 and 400 mg/kg, 
respectively) and galantamine (3 mg/kg) had 
significantly higher CAT activities than aged 
control mice (p < 0.05). 
 
Table 2: Effect of CDME on CAT activityin mouse 
brain tissue 
 
Group CDME (mg/kg) CAT activity (U/mg pro) 
Controla 0 122.7±14.8* 
Agedb 0 72.8±12.4 
Galc 3 96.3±15.3** 
L-CDMEd 100 78.7±12.6 
M-CDMEe 200 86.4±11.5** 
H-CDME 400 111.2±10.7** 
a15-month-old control; baged control; cgalantamine; 
dlow dose of CDME; emiddle dose of CDME; fhigh 
dose of CDME;*significantly different (p < 0.05) versus 
15-month-old control group (n = 10); **significantly 
different (p < 0.05) versus aged control group (n = 10) 
 
Effect of CDMEon AChE activity in mouse 
brain tissue  
 
As shown in Table 3, the aged mice showed 
increased AChE activity was significantly 
increased in the brain tissue of aged control mice 
compared with the 15-month-old normal control 
mice (p < 0.05). On the contrary, the activities of 
AChE in the brain tissue of mice markedly 
decrease (p < 0.05) when treated with CDME 
(200 and 400 mg/kg) and galantamine (3 mg/kg).  
 
Table 3: Effect of CDME on AChE activity in mouse 
brain tissue 
 
Group CDME (mg/kg) 
AChE activity (U/mg 
pro) 
Controla 0 1.27±0.21* 
Agedb 0 1.76±0.14 
Galc 3 0.92±0.15* 
L-CDMEd 100 1.65±0.12 
M-CDMEe 200 1.51±0.16* 
H-CDMEf 400 0.87±0.12* 
a15-month-old control; baged control; cgalantamine; 
dlow dose of CDME; emiddle dose of CDME; fhigh 
dose of CDME; *significantly different (p < 0.05) versus 




Learning and memory abilities are important 
functions of the brain in humans and rodents. 
Aging in humans is associated with deterioration 
of cognitive performance, particularly learning 
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and memory abilities [13]. Aging animals have 
traditionally been used as a model of memory 
impairment [14]. Behavioral tests are one of the 
most reliable methods of investigating learning 
and memory abilities of animals. Cistanche 
deserticola Ma has been used as memory 
enhancer in Asia for thousands of years. Various 
animal models have demonstrated that 
Cistanche deserticola Ma can improve brain 
functions [15]. In the present study, the memory-
enhancing effects of CDME on normal aged mice 
were investigated by using an open-field test. 
 
The exact mechanisms responsible for the 
memory impairments with aging are still unclear, 
but evidence has accumulated that oxidative 
stress plays an important role [16]. Oxidative 
stress occurs when pro-oxidant and antioxidant 
levels become imbalanced. With aging, there is 
an increased production of reactive oxygen 
species and diminished endogenous antioxidant 
enzyme levels, leading to an increased oxidizing 
cellular environment. CAT, the main endogenous 
antioxidant enzyme, plays an important role in 
the intracellular antioxidant defense in the brain. 
Our study results showed that decreasing 
activities of CAT in the aged control mice could 
be partly reversed by CDME. These findings 
demonstrate that the memory-enhancing effects 
of CDME on the aged mice may be via the 
antioxidant system. 
 
Aging is often accompanied by some alterations 
in neurotransmitter systems, such as 
acetylcholine andmonoamine transmitters 
[17,18]. The transmissionof these 
neurotransmitters in the brain has been long 
considered an important modulator of synaptic 
plasticity, memory consolidation, and other 
cognitive processes [19]. Under normal 
conditions, metabolic controls that are 
responsible for maintaining the levels of ACh and 
monoamine transmitters are catalyzed by AChE 
[20]. Our experimental data suggest that the 
CDME-mediated enhancement in spatial and 
non-spatial learning and memory abilities could 
be, at least partially, due to the decreasing 
activity of AChE in aged control mice. This 





The findings of this study indicate that CDME 
ameliorates learning and memory deficits in aged 
mice. Thus, CDME is a promising treatment for 
enhancing memory but further studies are 
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